The FDA issued guidance in August 2023 to provide more clarity to IRBs, clinical investigators, and sponsors in complying with FDA’s informed…
Read More
During its meeting on July 19-20, 2023, SACHRP advanced its work toward completing one of the recommendations contained in this…
Read More